Bharat Biotech Allowed To Conduct Vaccine Trials On Children Above 12 | Read
PUBLISHED ON: January 4, 2021 | Duration: 2 min, 38 sec
Bharat Biotech, which received emergency approval for its Covid-19 vaccine only in "clinical trial mode", is allowed to conduct its trials on children who are above the age of 12 years. The vaccine has already been used for children above 12 in the last round and has been found safe. The Hyderabad-based firm is conducting Phase 3 trials.